Matthieu Frédéric Bal

Title: Matthieu Frédéric Bal: Innovator in Radiation Therapy

Introduction

Matthieu Frédéric Bal is a notable inventor based in Geldrop, Netherlands. He has made significant contributions to the field of radiation therapy, holding a total of 7 patents. His work focuses on enhancing the personalization of cancer treatment, particularly for patients undergoing radiation therapy.

Latest Patents

One of his latest patents involves systems and methods to support the personalization of cancer treatment for patients undergoing radiation therapy. This innovation estimates a patient-specific toxicity risk for radiation therapy side effects using a Bayesian network that incorporates values of biomarkers from the patient. The patent outlines an optimized patient-specific radiation therapy plan that adapts based on updated biomarker values during treatment. Another significant patent focuses on the fast generation of multi-leaf collimator (MLC) openings. This device optimizes radiation therapy plans by adjusting MLC settings through a method that increases resolution in successive iterations.

Career Highlights

Throughout his career, Matthieu has worked with prominent organizations, including Koninklijke Philips Corporation N.V. and The General Hospital Corporation. His expertise in radiation therapy has positioned him as a key figure in the development of innovative treatment methods.

Collaborations

Matthieu has collaborated with notable professionals in his field, including Alfonso Agatino Isola and Thomas Bortfeld. These collaborations have further enriched his contributions to radiation therapy innovations.

Conclusion

Matthieu Frédéric Bal's work exemplifies the intersection of technology and healthcare, particularly in the realm of personalized cancer treatment. His patents and career achievements reflect a commitment to improving patient outcomes through innovative solutions.